- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1993
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cannabidiol and Other Phytocannabinoids as Cancer Therapeutics ; volume:36 ; number:2 ; day:4 ; month:3 ; year:2022 ; pages:99-129 ; date:4.2022
Pharmaceutical medicine ; 36, Heft 2 (4.3.2022), 99-129, 4.2022
- Urheber
-
Nahler, Gerhard
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40290-022-00420-4
- URN
-
urn:nbn:de:101:1-2022070306574929837257
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Nahler, Gerhard
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cannabinoids as therapeutics
Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics
Digitoxin and its analogs as novel cancer therapeutics
Cannabidiol as a treatment for epilepsy
Immune checkpoint inhibitors of PD-L1 as cancer therapeutics
Novel EGFR family member binding antibodies as cancer therapeutics
Does Cannabidiol Have a Benefit as a Supportive Care Drug in Cancer?
Anaplastic thyroid cancer spheroids as preclinical models to test therapeutics
Recent developments in mushrooms as anti-cancer therapeutics: a review
SPACA6P-AS: a trailblazer in breast cancer pathobiology and therapeutics
Cancer vaccines as promising immuno-therapeutics: platforms and current progress
Targeting CDK9 for anti-cancer therapeutics
Cannabinoids as therapeutics
Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics
Digitoxin and its analogs as novel cancer therapeutics
Cannabidiol as a treatment for epilepsy
Immune checkpoint inhibitors of PD-L1 as cancer therapeutics
Novel EGFR family member binding antibodies as cancer therapeutics
Does Cannabidiol Have a Benefit as a Supportive Care Drug in Cancer?
Anaplastic thyroid cancer spheroids as preclinical models to test therapeutics
Recent developments in mushrooms as anti-cancer therapeutics: a review
SPACA6P-AS: a trailblazer in breast cancer pathobiology and therapeutics
Cancer vaccines as promising immuno-therapeutics: platforms and current progress
Targeting CDK9 for anti-cancer therapeutics
Cannabinoids as therapeutics
Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics
Digitoxin and its analogs as novel cancer therapeutics
Cannabidiol as a treatment for epilepsy
Immune checkpoint inhibitors of PD-L1 as cancer therapeutics
Novel EGFR family member binding antibodies as cancer therapeutics
Does Cannabidiol Have a Benefit as a Supportive Care Drug in Cancer?
Anaplastic thyroid cancer spheroids as preclinical models to test therapeutics
Recent developments in mushrooms as anti-cancer therapeutics: a review
SPACA6P-AS: a trailblazer in breast cancer pathobiology and therapeutics
Cancer vaccines as promising immuno-therapeutics: platforms and current progress